Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer
NCT00522795Phase 2Completed
- Sponsor
- Brown University
- Start
- Aug 2007
- Primary completion
- Feb 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in esophageal cancer, gastroesophageal junction cancer, sponsored by Brown University. Started Aug 2007; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
esophageal cancergastroesophageal junction cancer
Beyond the preview
Go deeper on NCT00522795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522795.